Cargando…
First person – Andreia Nunes
First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Andreia Nunes is first author on ‘ Identification of candidate miRNA biomarkers for faciosc...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405848/ http://dx.doi.org/10.1242/dmm.049244 |
_version_ | 1783746400716062720 |
---|---|
collection | PubMed |
description | First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Andreia Nunes is first author on ‘ Identification of candidate miRNA biomarkers for facioscapulohumeral muscular dystrophy using DUX4-based mouse models’, published in DMM. Andreia is a postdoc in the lab of Peter L. Jones at the University of Nevada, Reno School of Medicine, Reno, NV, USA, investigating therapeutics for and disease mechanisms of facioscapulohumeral muscular dystrophy. |
format | Online Article Text |
id | pubmed-8405848 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Company of Biologists Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-84058482021-08-31 First person – Andreia Nunes Dis Model Mech First Person First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Andreia Nunes is first author on ‘ Identification of candidate miRNA biomarkers for facioscapulohumeral muscular dystrophy using DUX4-based mouse models’, published in DMM. Andreia is a postdoc in the lab of Peter L. Jones at the University of Nevada, Reno School of Medicine, Reno, NV, USA, investigating therapeutics for and disease mechanisms of facioscapulohumeral muscular dystrophy. The Company of Biologists Ltd 2021-08-24 /pmc/articles/PMC8405848/ http://dx.doi.org/10.1242/dmm.049244 Text en © 2021. Published by The Company of Biologists Ltd https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed. |
spellingShingle | First Person First person – Andreia Nunes |
title | First person – Andreia Nunes |
title_full | First person – Andreia Nunes |
title_fullStr | First person – Andreia Nunes |
title_full_unstemmed | First person – Andreia Nunes |
title_short | First person – Andreia Nunes |
title_sort | first person – andreia nunes |
topic | First Person |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405848/ http://dx.doi.org/10.1242/dmm.049244 |